Researchers discover new insights into how dual-target drug may supercharge cancer-fighting immune cells. Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory ...

The US FDA has provided further clarification on Neurizon’s IND application for NUZ-001. ... Read More The post ‘One straightforward request’: Neurizon buoyant on FDA clarity appeared first on ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

These programmes are a beacon, offering routes to explore investigational drugs outside the typical confines of clinical trials. 2 They stand as lifelines for those who have journeyed through ...

Trump’s desk to help protect animals from mandatory testing at the FDA,” said Kennedy. “It’s been over two years since Congress ended the statutory mandate that investigational new drugs ...

(NASDAQ: MDCX) (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce that its Investigational New Animal Drug (INAD File No.013880) has received Minor Use in Major Species Designation ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

has granted the Company a sponsor fee waiver and assigned an Investigational New Animal Drug (INAD) number for its LPT-CBD (Liposome Platform Technology-Cannabidiol) product. This represents a ...